Literature DB >> 28121634

Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Correlation of Histopathology and MRI in Prion Disease.

Karin P Mente1, James K O'Donnell, Stephen E Jones, Mark L Cohen, Nicolas R Thompson, Alberto Bizzi, Pierluigi Gambetti, Jiri G Safar, Brian S Appleby.   

Abstract

Creutzfeldt-Jakob disease (CJD) and other prion diseases are rapidly progressive spongiform encephalopathies that are invariably fatal. Clinical features and magnetic resonance imaging, electroencephalogram, and cerebrospinal fluid abnormalities may suggest prion disease, but a definitive diagnosis can only be made by means of neuropathologic examination. Fluorodeoxyglucose positron emission tomography (FDG-PET) is not routinely used to evaluate patients with suspected prion disease. This study includes 11 cases of definite prion disease in which FDG-PET scans were obtained. There were 8 sporadic CJD cases, 2 genetic CJD cases, and 1 fatal familial insomnia case. Automated FDG-PET analysis revealed parietal region hypometabolism in all cases. Surprisingly, limbic and mesolimbic hypermetabolism were also present in the majority of cases. When FDG-PET hypometabolism was compared with neuropathologic changes (neuronal loss, astrocytosis, spongiosis), hypometabolism was predictive of neuropathology in 80.6% of cortical regions versus 17.6% of subcortical regions. The odds of neuropathologic changes were 2.1 times higher in cortical regions than subcortical regions (P=0.0265). A similar discordance between cortical and subcortical regions was observed between FDG-PET hypometabolism and magnetic resonance imaging diffusion weighted imaging hyperintensity. This study shows that there may be a relationship between FDG-PET hypometabolism and neuropathology in cortical regions in prion disease but it is unlikely to be helpful for diagnosis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28121634      PMCID: PMC5322151          DOI: 10.1097/WAD.0000000000000188

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  31 in total

1.  Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion.

Authors:  Ryuichiro Atarashi; Katsuya Satoh; Kazunori Sano; Takayuki Fuse; Naohiro Yamaguchi; Daisuke Ishibashi; Takehiro Matsubara; Takehiro Nakagaki; Hitoki Yamanaka; Susumu Shirabe; Masahito Yamada; Hidehiro Mizusawa; Tetsuyuki Kitamoto; Genevieve Klug; Amelia McGlade; Steven J Collins; Noriyuki Nishida
Journal:  Nat Med       Date:  2011-01-30       Impact factor: 53.440

2.  A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease.

Authors:  Clive Hamlin; Gianfranco Puoti; Sally Berri; Elliott Sting; Carrie Harris; Mark Cohen; Charles Spear; Alberto Bizzi; Sara M Debanne; Douglas Y Rowland
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

Review 3.  Molecular biology and pathology of prion strains in sporadic human prion diseases.

Authors:  Pierluigi Gambetti; Ignazio Cali; Silvio Notari; Qingzhong Kong; Wen-Quan Zou; Witold K Surewicz
Journal:  Acta Neuropathol       Date:  2010-11-07       Impact factor: 17.088

4.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

5.  Glucose metabolism in sporadic Creutzfeldt-Jakob disease: a statistical parametric mapping analysis of (18) F-FDG PET.

Authors:  E-J Kim; S-S Cho; B-H Jeong; Y-S Kim; S W Seo; D L Na; M D Geschwind; Y Jeong
Journal:  Eur J Neurol       Date:  2011-11-04       Impact factor: 6.089

6.  Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.

Authors:  M Higuchi; M Tashiro; H Arai; N Okamura; S Hara; S Higuchi; M Itoh; R W Shin; J Q Trojanowski; H Sasaki
Journal:  Exp Neurol       Date:  2000-04       Impact factor: 5.330

7.  Sporadic Creutzfeldt-Jakob disease: the extent of microglia activation is dependent on the biochemical type of PrPSc.

Authors:  Gianfranco Puoti; Giorgio Giaccone; Michela Mangieri; Lucia Limido; Paolo Fociani; Pietro Zerbi; Silvia Suardi; Giacomina Rossi; Selina Iussich; Raffaella Capobianco; Giuseppe Di Fede; Gabriella Marcon; Roberto Cotrufo; Graziella Filippini; Orso Bugiani; Fabrizio Tagliavini
Journal:  J Neuropathol Exp Neurol       Date:  2005-10       Impact factor: 3.685

8.  Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease.

Authors:  Bernhard J Steinhoff; Inga Zerr; Maya Glatting; Walter Schulz-Schaeffer; Sigrid Poser; Hans A Kretzschmar
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

9.  14-3-3 protein in the CSF of patients with rapidly progressive dementia.

Authors:  N Huang; S K Marie; J A Livramento; R Chammas; R Nitrini
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

10.  Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis.

Authors:  Marco Pagani; Adriano Chiò; Maria Consuelo Valentini; Johanna Öberg; Flavio Nobili; Andrea Calvo; Cristina Moglia; Davide Bertuzzo; Silvia Morbelli; Fabrizio De Carli; Piercarlo Fania; Angelina Cistaro
Journal:  Neurology       Date:  2014-08-13       Impact factor: 9.910

View more
  12 in total

1.  Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.

Authors:  Adam M Staffaroni; Lynn Bajorek; Kaitlin B Casaletto; Yann Cobigo; Sheng-Yang M Goh; Amy Wolf; Hilary W Heuer; Fanny M Elahi; Peter A Ljubenkov; Reilly Dever; John Kornak; Brian Appleby; Jessica Bove; Yvette Bordelon; Patrick Brannelly; Danielle Brushaber; Christina Caso; Giovanni Coppola; Christina Dheel; Bradford C Dickerson; Susan Dickinson; Sophia Dominguez; Kimiko Domoto-Reilly; Kelly Faber; Jessica Ferrall; Julie A Fields; Ann Fishman; Jamie Fong; Tatiana Foroud; Leah K Forsberg; Ralitza Gavrilova; Debra Gearhart; Behnaz Ghazanfari; Nupur Ghoshal; Jill Goldman; Jonathan Graff-Radford; Neill Graff-Radford; Ian Grant; Murray Grossman; Dana Haley; Ging-Yuek Hsiung; Edward D Huey; David J Irwin; David T Jones; Lynne Jones; Kejal Kantarci; Anna Karydas; Daniel I Kaufer; Diana R Kerwin; David S Knopman; Ruth Kraft; Walter K Kremers; Walter A Kukull; Irene Litvan; Diane Lucente; Codrin Lungu; Ian R Mackenzie; Miranda Maldonado; Masood Manoochehri; Scott M McGinnis; Emily McKinley; Mario F Mendez; Bruce L Miller; Namita Multani; Chiadi Onyike; Jaya Padmanabhan; Alex Pantelyat; Rodney Pearlman; Len Petrucelli; Madeline Potter; Rosa Rademakers; Eliana Marisa Ramos; Katherine P Rankin; Katya Rascovsky; Erik D Roberson; Emily Rogalski; Pheth Sengdy; Leslie M Shaw; Jeremy Syrjanen; M Carmela Tartaglia; Nadine Tatton; Joanne Taylor; Arthur Toga; John Q Trojanowski; Sandra Weintraub; Ping Wang; Bonnie Wong; Zbigniew Wszolek; Adam L Boxer; Brad F Boeve; Joel H Kramer; Howard J Rosen
Journal:  Alzheimers Dement       Date:  2019-05-11       Impact factor: 21.566

2.  Amyloid- and FDG-PET in sporadic Creutzfeldt-Jakob disease: Correlation with pathological prion protein in neuropathology.

Authors:  Jordi A Matías-Guiu; Carmen Guerrero-Márquez; María Nieves Cabrera-Martín; Ulises Gómez-Pinedo; María Romeral; Diego Mayo; Jesús Porta-Etessam; Teresa Moreno-Ramos; José Luis Carreras; Jorge Matías-Guiu
Journal:  Prion       Date:  2017-05-16       Impact factor: 3.931

3.  Wernicke-Korsakoff syndrome as a rare phenotype of sporadic Creutzfeldt-Jakob disease.

Authors:  Joanna Bielewicz; Anna Szczepańska-Szerej; Magdalena Ogórek; Piotr Dropko; Katarzyna Wojtal; Konrad Rejdak
Journal:  Prion       Date:  2018-02-09       Impact factor: 3.931

4.  Combined findings of FDG-PET and arterial spin labeling in sporadic Creutzfeldt-Jakob disease.

Authors:  Junliang Yuan; Shuangkun Wang; Wenli Hu
Journal:  Prion       Date:  2018-10-09       Impact factor: 3.931

5.  Author response: In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease.

Authors:  Gregory S Day; Brian A Gordon; Richard J Perrin; Beau M Ances
Journal:  Neurology       Date:  2019-01-15       Impact factor: 9.910

Review 6.  Multiparametric magnetic resonance imaging and positron emission tomography findings in neurodegenerative diseases: Current status and future directions.

Authors:  Neetu Soni; Manish Ora; Girish Bathla; Chandana Nagaraj; Laura L Boles Ponto; Michael M Graham; Jitender Saini; Yusuf Menda
Journal:  Neuroradiol J       Date:  2021-03-05

7.  Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes.

Authors:  Marco Pagani; Adriano Chiò; Antonio Canosa; Andrea Calvo; Cristina Moglia; Rosario Vasta; Francesca Palumbo; Luca Solero; Francesca Di Pede; Sara Cabras; Vincenzo Arena; Grazia Zocco; Federico Casale; Maura Brunetti; Luca Sbaiz; Salvatore Gallone; Maurizio Grassano; Umberto Manera
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-25       Impact factor: 10.057

8.  Report of a Case of Creutzfeldt-Jakob Disease With an Unusual Clinical Presentation.

Authors:  Elena Prodi; Stefania Rossi; Ilaria Bertaina; Emanuele Pravatà; Leonardo Sacco
Journal:  Front Behav Neurosci       Date:  2020-04-09       Impact factor: 3.558

9.  Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury.

Authors:  Leonie Beyer; Alexander Nitschmann; Henryk Barthel; Thilo van Eimeren; Marcus Unterrainer; Julia Sauerbeck; Ken Marek; Mengmeng Song; Carla Palleis; Gesine Respondek; Jochen Hammes; Michael T Barbe; Özgür Onur; Frank Jessen; Dorothee Saur; Matthias L Schroeter; Jost-Julian Rumpf; Michael Rullmann; Andreas Schildan; Marianne Patt; Bernd Neumaier; Olivier Barret; Jennifer Madonia; David S Russell; Andrew W Stephens; Sigrun Roeber; Jochen Herms; Kai Bötzel; Johannes Levin; Joseph Classen; Günter U Höglinger; Peter Bartenstein; Victor Villemagne; Alexander Drzezga; John Seibyl; Osama Sabri; Matthias Brendel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-04-21       Impact factor: 9.236

Review 10.  Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies.

Authors:  Lucas M Ascari; Stephanie C Rocha; Priscila B Gonçalves; Tuane C R G Vieira; Yraima Cordeiro
Journal:  Front Bioeng Biotechnol       Date:  2020-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.